Carbohydrate antigen 125 in heart failure: congestive kidneys or beyond?
作者信息
Higgins Andrew, Tang W H Wilson
机构信息
Department of Cardiovascular Medicine, Kaufman Center for Heart Failure Treatment and Recovery, Cleveland Clinic, 9500 Euclid Avenue, Desk J3-4, Cleveland, OH 44195, USA.
出版信息
Eur Heart J Acute Cardiovasc Care. 2021 Jun 30;10(5):484-486. doi: 10.1093/ehjacc/zuab027.
Abstract
摘要
相似文献
1
Carbohydrate antigen 125 in heart failure: congestive kidneys or beyond?心力衰竭中的糖类抗原125：充血性肾病还是其他？
Eur Heart J Acute Cardiovasc Care. 2021 Jun 30;10(5):484-486. doi: 10.1093/ehjacc/zuab027.
2
Carbohydrate antigen 125; A biomarker not only for medical patients but also for surgical patients with heart failure.糖类抗原125；一种不仅适用于内科患者，也适用于心力衰竭外科患者的生物标志物。
Int J Cardiol. 2023 Feb 15;373:80. doi: 10.1016/j.ijcard.2022.11.046. Epub 2022 Nov 26.
3
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review.抗原碳水化合物 125 作为心力衰竭的生物标志物：叙述性综述。
Eur J Heart Fail. 2021 Sep;23(9):1445-1457. doi: 10.1002/ejhf.2295. Epub 2021 Jul 20.
4
CA125 but not NT-proBNP predicts the presence of a congestive intrarenal venous flow in patients with acute heart failure.CA125 而非 NT-proBNP 可预测急性心力衰竭患者存在充血性肾内静脉血流。
Eur Heart J Acute Cardiovasc Care. 2021 Jun 30;10(5):475-483. doi: 10.1093/ehjacc/zuab022.
5
6
Can Carbohydrate Antigen-125 Be a New Biomarker to Guide Heart Failure Treatment?: The CHANCE-HF Trial.糖类抗原-125能否成为指导心力衰竭治疗的新型生物标志物？：CHANCE-HF试验
JACC Heart Fail. 2016 Nov;4(11):844-846. doi: 10.1016/j.jchf.2016.09.001.
7
Carbohydrate Antigen-125 in Heart Failure: An Overlooked Biomarker of Congestion.心力衰竭中的糖类抗原-125：一种被忽视的充血生物标志物。
JACC Heart Fail. 2018 May;6(5):441-442. doi: 10.1016/j.jchf.2018.01.006.
8
Reply: Carbohydrate Antigen-125 in Heart Failure: An Overlooked Biomarker of Congestion.回复：心力衰竭中的糖类抗原125：一种被忽视的充血生物标志物。
JACC Heart Fail. 2018 May;6(5):442-443. doi: 10.1016/j.jchf.2018.02.013.
9
Estimation of CA 125 concentration in patients with congestive heart failure.
Ann Univ Mariae Curie Sklodowska Med. 2004;59(1):261-4.
10
Heart Failure With Preserved Ejection Fraction: A Kidney Disorder?射血分数保留的心力衰竭：一种肾脏疾病？
Circulation. 2016 Aug 9;134(6):435-7. doi: 10.1161/CIRCULATIONAHA.116.022249.
引用本文的文献
1
CA125 as a Potential Biomarker in Non-Malignant Serous Effusions: Diagnostic and Prognostic Considerations.CA125作为非恶性浆液性积液中的潜在生物标志物：诊断和预后考量
J Clin Med. 2025 Jun 11;14(12):4152. doi: 10.3390/jcm14124152.
2
CA125, Galectin-3 and FGF-23 are interrelated in heart failure with reduced ejection fraction.在射血分数降低的心力衰竭中，CA125、半乳糖凝集素-3和FGF-23相互关联。
EJIFCC. 2023 Jul 10;34(2):103-109. eCollection 2023 Jul.
本文引用的文献
1
The Effect of Decongestion on Intrarenal Venous Flow Patterns in Patients With Acute Heart Failure.充血消退对急性心力衰竭患者肾内静脉血流模式的影响。
J Card Fail. 2021 Jan;27(1):29-34. doi: 10.1016/j.cardfail.2020.09.003. Epub 2020 Sep 11.
2
Prognostic Impact of Changes in Intrarenal Venous Flow Pattern in Patients With Heart Failure.心力衰竭患者肾内静脉血流模式变化的预后影响
J Card Fail. 2021 Jan;27(1):20-28. doi: 10.1016/j.cardfail.2020.06.016. Epub 2020 Jul 9.
3
Epidemiology of heart failure.心力衰竭的流行病学。
Eur J Heart Fail. 2020 Aug;22(8):1342-1356. doi: 10.1002/ejhf.1858. Epub 2020 Jun 1.
4
Sodium glucose cotransporter 2 inhibitors as diuretic adjuvants in acute decompensated heart failure: a case series.钠-葡萄糖协同转运蛋白2抑制剂作为急性失代偿性心力衰竭利尿剂辅助药物的病例系列
ESC Heart Fail. 2020 Aug;7(4):1966-1971. doi: 10.1002/ehf2.12759. Epub 2020 May 31.
5
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.维立西呱治疗射血分数降低的心力衰竭患者的疗效。
N Engl J Med. 2020 May 14;382(20):1883-1893. doi: 10.1056/NEJMoa1915928. Epub 2020 Mar 28.
6
Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.CA125 在心力衰竭恶化中的临床作用：BIOSTAT-CHF 研究的亚组分析。
JACC Heart Fail. 2020 May;8(5):386-397. doi: 10.1016/j.jchf.2019.12.005. Epub 2020 Mar 11.
7
Biomarkers of Congestion: Emerging Tools in the Management of Heart Failure?充血的生物标志物：心力衰竭管理中的新兴工具？
JACC Heart Fail. 2020 May;8(5):398-400. doi: 10.1016/j.jchf.2020.01.006. Epub 2020 Mar 11.
8
CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction.CA125 指导的利尿剂治疗与急性心力衰竭伴肾功能障碍患者的常规治疗比较。
Am J Med. 2020 Mar;133(3):370-380.e4. doi: 10.1016/j.amjmed.2019.07.041. Epub 2019 Aug 15.
9
Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals.心力衰竭发病率的时间趋势和模式：一项基于 400 万人的人群研究。
Lancet. 2018 Feb 10;391(10120):572-580. doi: 10.1016/S0140-6736(17)32520-5. Epub 2017 Nov 21.
10
Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial.急性心力衰竭住院期间及出院后的体重变化：患者特征、充血标志物及预后：ASCEND-HF试验的结果
JACC Heart Fail. 2017 Jan;5(1):1-13. doi: 10.1016/j.jchf.2016.09.012.
Zotero 插件